Meeting HighlightsThe 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations
The Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC) to accelerate the development of new cancer therapies, new strategies for early detection and prevention, and improve cancer care and the quality of life for patients and their families. The 4th MSCS-CRC (September 25-27, 2024, Buffalo, New York) brought together 147 participants from the US, Canada, Croatia, Czechia, Lithuania, Poland, Romania and Ukraine, and involved representatives of the US Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI) and their counterparts from Poland, Ukraine Lithuania and other CEECs. They were accompanied by New York State (NYS) and local representatives of the NYS Empire State Development, and of the Translational Research Consortium of Cancer Centers (TRCCC), involving 13 cancer centers from the Northeastern US and Canada, as well as several Pharma and Biotech companies. The 4th Meeting focused on prevention and early detection of smoking- and HPV-related cancers, reducing disparities in cancer detection-, care and outcomes, and increasing the feasibility and reducing costs of high-end treatments, such as cell therapies for patients with advanced cancers. The second focus area were the available sources of funding of regional and international collaborations in these areas. The relevance of the successful model TRCC to promoting the oncology training and research collaborations in the CEE Countries was discussed. The 5th MSCR-CRC meeting will take place September 3-5, 2025, in Warsaw, Poland.
Authors
- Szabolcs Bozsányi (ORCID: https://orcid.org/0000-0002-1391-419X)
- Edita Sužiedėlienė
- Joanna Stanson
- Andriy Beznosenko (ORCID: https://orcid.org/0000-0003-2293-3488)
- Leszek Kotula (ORCID: https://orcid.org/0000-0002-7977-7124)
- Kathleen M. Kokolus (ORCID: https://orcid.org/0000-0002-9088-5409)
- Smitha R. James
- Paweł Koczkodaj (ORCID: https://orcid.org/0000-0002-7525-0181)
- Kaushal Nanavati
- Cristian Virgil Lungulescu (ORCID: https://orcid.org/0000-0003-3578-3562)
- Dylan Williams
- Ioana Stanciu (ORCID: https://orcid.org/0000-0002-0808-0717)
- Andrew Hyland (ORCID: https://orcid.org/0009-0009-6318-9932)
- Łukasz Balwicki (ORCID: https://orcid.org/0000-0002-8821-7911)
- Mark Parascandola (ORCID: https://orcid.org/0000-0001-6071-8493)
- Khurshid A. Guru (ORCID: https://orcid.org/0000-0002-4551-4676)
- Iwona Ługowska (ORCID: https://orcid.org/0000-0001-9511-178X)
- Katia Noyes (ORCID: https://orcid.org/0000-0002-0725-8448)
- Blanka Borowiec (ORCID: https://orcid.org/0000-0002-1109-9240)
- Kęstutis Sužiedėlis (ORCID: https://orcid.org/0000-0002-9485-3674)
- Christine E. Sheffer (ORCID: https://orcid.org/0000-0002-3741-5774)
- Wojciech Fendler (ORCID: https://orcid.org/0000-0002-5083-9168)
- Mihaela Balu (ORCID: https://orcid.org/0000-0002-8018-5134)
- Karolina M. Nowak (ORCID: https://orcid.org/0000-0003-1394-728X)
- Paweł Kaliński (ORCID: https://orcid.org/0000-0001-7025-3562)
- Sandro Matosevic (ORCID: https://orcid.org/0000-0001-5118-2455)
- Waldemar Priebe (ORCID: https://orcid.org/0000-0003-4522-4772)
- Ioana Berindan‐Neagoe (ORCID: https://orcid.org/0000-0001-5828-1325)
- Mark Wojtowicz (ORCID: https://orcid.org/0000-0003-2892-9404)
- Rūta Everatt (ORCID: https://orcid.org/0000-0003-4887-8894)
- Wei‐Zen Wei (ORCID: https://orcid.org/0000-0001-6036-3610)
- Iva Kirac (ORCID: https://orcid.org/0000-0002-6507-8875)
- Anda Vlad (ORCID: https://orcid.org/0000-0001-5266-9695)
- Tomasz Roman Zdrojewski (ORCID: https://orcid.org/0000-0001-6015-8561)
- Piotr Rutkowski (ORCID: https://orcid.org/0000-0002-8920-5429)
- Jonathan L. Bramson (ORCID: https://orcid.org/0000-0003-2874-6886)
- Jeffrey E. Gershenwald (ORCID: https://orcid.org/0000-0003-4519-5369)
- Elizabeth Luke
- Mukund Seshadri (ORCID: https://orcid.org/0000-0001-8729-9532)
- Maciej Lukasz Goniewicz (ORCID: https://orcid.org/0000-0001-6748-3068)
- Mikhail Y. Berezin (ORCID: https://orcid.org/0000-0002-2670-2487)
- Brian J. Czerniecki (ORCID: https://orcid.org/0000-0002-1908-7404)
- Peter Forsyth (ORCID: https://orcid.org/0000-0001-7841-7891)
- Indu B. Ahluwalia
- Michael J. Nemeth
- Telisa Stewart
- Maciej Łuba
- Iryna Tanasiichuk
- Brygida Baran
- Loretta Beine
Institutions
- Poznan University of Medical Sciences (PL)
- Centers for Disease Control and Prevention (US)
- Roswell Park Comprehensive Cancer Center (US)
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- University Hospital Centre Zagreb (HR)
- Carol Davila University of Medicine and Pharmacy (RO)
- Vilnius University (LT)
- SUNY Upstate Medical University (US)
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Purdue University West Lafayette (US)
- Medical University of Warsaw (PL)
- Empire State Development (US)
- University of Medicine and Pharmacy of Craiova (RO)
- Moffitt Cancer Center (US)
- The Barbara Ann Karmanos Cancer Institute (US)
- Office of the Director (US)
- Emergency University (US)
- Industrial Development Agency JSC (Poland) (PL)
- Dana-Farber Cancer Institute (US)
- National Institute of Oncology (HU)
- National Cancer Institute (UA)
- LaCell (United States) (US)
- Irvine University (US)
- National Cancer Institute (US)
- National Cancer Institute (LT)
- University at Buffalo, State University of New York (US)
- Gdańsk Medical University (PL)
- Bogomolets National Medical University (UA)
- University of Craiova (RO)
- McMaster University (CA)
Publication Details
- Journal
- Wiadomości Lekarskie
- Published
- 2025-02-28
- DOI
- https://doi.org/10.36740/wlek/202370
- Primary Topic
- Advances in Oncology and Radiotherapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Genentech